Myderm Pro Freeze Cooling Menthol Pain Relief Roll-on

Description

No description information is available for the drug.

Uses and Indications

MyDerm Freeze is indicated for the temporary relief of minor aches and pains of muscles and joints.

There are no known teratogenic effects associated with MyDerm Freeze. Additionally, the product insert does not mention any nonteratogenic effects.

Dosage and Administration

The medication should be applied to the affected area no more than 3 to 4 times daily. Healthcare professionals are advised to instruct patients to use the product as directed, ensuring that the application is limited to the specified frequency to avoid potential adverse effects. It is important to monitor the area for any signs of irritation or adverse reactions following application.

Contraindications

The product is contraindicated for application to wounds or damaged skin, as well as to irritated skin, due to the potential for exacerbating the condition. Additionally, it should not be bandaged, as this may alter the intended effects. The use of heating pads or devices in conjunction with the product is also contraindicated, as it may lead to adverse reactions.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes or mucous membranes when using this product. Application to wounds, damaged skin, or irritated skin is contraindicated. Additionally, the product should not be bandaged after application. Users are advised to wash their hands thoroughly with cool water following use. The product should not be used in conjunction with heating pads or devices.

In the event of accidental ingestion, it is crucial to keep the product out of reach of children. Immediate medical assistance should be sought, or contact a poison control center without delay.

Users should discontinue use and consult a healthcare professional if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then reoccur within a few days.

Side Effects

For external use only. Patients should discontinue use and consult a doctor if the condition worsens, if symptoms persist for more than 7 days, or if the condition cleans up and recurs within a few days. No specific side effects or adverse reactions have been reported in clinical trials or postmarketing experiences.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Myderm Pro Freeze Cooling Menthol Pain Relief Roll-on (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored when using this product. It is essential to keep the product out of reach of children; in the event of accidental ingestion, medical assistance or contact with a poison control center is necessary immediately. The product is intended for external use only and should not come into contact with the eyes or mucous membranes.

Application should be avoided on wounds, damaged skin, or irritated areas. Bandaging the treated area is not recommended, and hands should be washed thoroughly with cool water after application. The use of heating pads or devices in conjunction with this product is contraindicated.

If the condition worsens, or if symptoms persist for more than 7 days, or if symptoms reoccur within a few days, the patient should discontinue use and consult a healthcare professional.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Safety during pregnancy has not been established for this medication. It is not recommended for use during pregnancy due to potential risks to the developing fetus. The effects on fetal development are currently unknown; therefore, caution is advised when considering this medication for pregnant patients.

Women of childbearing potential should consult a healthcare provider before using this medication if they are pregnant or planning to become pregnant. It is essential to evaluate the potential risks and benefits in these situations.

Lactation

There are no specific warnings or recommendations regarding the use of MyDerm Pro Freeze Cooling Menthol Pain Relief Roll-On in lactating mothers. Additionally, there is no information available concerning the potential for excretion of the product in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while no specific overdosage information is provided, healthcare professionals should exercise caution, remain alert to potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children and to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. Patients should be instructed to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms reoccur within a few days after initial improvement.

It is important for healthcare providers to emphasize that patients should avoid contact with the eyes and mucous membranes while using this product. Patients should also be cautioned against applying the product to wounds, damaged skin, or irritated skin. Additionally, patients should be informed not to bandage the area after application.

Healthcare providers should remind patients to wash their hands thoroughly with cool water after using the product. Lastly, patients should be advised not to use the product in conjunction with a heating pad or any heating device.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

Patients should apply the product to the affected area no more than 3 to 4 times daily. Clinicians should advise patients to avoid contact with the eyes or mucous membranes and not to apply the product to wounds, damaged, or irritated skin. Bandaging the area after application is not recommended. Patients are also instructed to wash their hands with cool water after use and to refrain from using the product in conjunction with heating pads or devices.

Patients should be counseled to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms reoccur within a few days. It is essential to keep the product out of reach of children, and in the event of ingestion, medical assistance or contact with a poison control center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Myderm Pro Freeze Cooling Menthol Pain Relief Roll-on, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)